Quantitative measurement of SC5b‐9 and C5b‐9(m) in infarcted areas of human myocardium

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Clinical and Experimental Immunology

• Publication date

  1990-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.1990.tb05303.xPMID 2379317PMCID PMC1535001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

  1988cited by this paper
• Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement.

  1987cited by this paper
• Damage to mammalian cells by proteins that form transmembrane pores.

  1987cited by this paper
• Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes.

  1986cited by this paper
• Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.

  1986cited by this paper
• Monoclonal Antibodies Recognizing a Neoantigen of Poly(C9) Detect the Human Terminal Complement Complex in Tissue and Plasma

  1985cited by this paper
• Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement

  1985cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• Membrane damage by complement.

  1983cited by this paper
• A simple immunoradiometric assay for the terminal SC5b-9 complex of human complement.

  1983cited by this paper
• Terminal membrane C5b-9 complex of human complement: transition from an amphiphilic to a hydrophilic state through binding of the S protein from serum

  1982cited by this paper
• Molecular weight

  1982cited by this paper
• Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer.

  1981cited by this paper
• Characterization of the binding of purified human C1q to heart mitochondrial membranes.

  1981cited by this paper
• Fluid-phase SC5b-8 complex of human complement: generation and isolation from serum.

  1981cited by this paper
• Direct measurement of the increase in intracellular free calcium ion concentration in response to the action of complement.

  1981cited by this paper
• Complement localization and mediation of ischemic injury in baboon myocardium.

  1980cited by this paper
• Human C5a and C5a analogs as probes of the neutrophil C5a receptor.

  1980cited by this paper
• Rapid increase in intracellular free Ca2+ induced by antibody plus complement

  1979cited by this paper
• In vitro activation of complement by isolated human heart subcellular membranes.

  1979cited by this paper
• In vitro activation of complement by isolated human heart subcellular membranes.

  1979cited by this paper
• Complement lysis: evidence for an amphiphilic nature of the terminal membrane C5b-9 complex of human complement.

  1978cited by this paper
• Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.

  1978cited by this paper
• Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

  1978cited by this paper
• Myocardial Consequences of Coronary Artery Bypass Graft Surgery: The Paradox of Necrosis in Areas of Revascularization

  1977cited by this paper
• The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.

  1975cited by this paper
• Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.

  1975cited by this paper
• Neoantigens of the membrane attack complex of human complement.

  1975cited by this paper
• Antibody-independent activation of human C1 after interaction with heart subcellular membranes.

  1973cited by this paper

• Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde.

  2022cites this paper
• Membrane Attack Complex in Myocardial Ischemia/Reperfusion Injury: A Systematic Review for Post Mortem Applications

  2020cites this paper
• Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers

  2018cites this paper
• Prehospital blood transfusion after combat injury and platelet function in an animal model of complex military trauma

  2017cites this paper
• Elevated C1rC1sC1inh levels independently predict atherosclerotic coronary heart disease.

  2013cites this paper
• The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.

  2013cites this paper
• Role of the Complement System in Ischaemic Heart Disease

  2012cites this paper
• The effect of C 1 inhibitor on myocardial ischemia and reperfusion injury

  2012cites this paper
• Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.

  2009cites this paper
• C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) C 1-inhibitor potentiation by glycosaminoglycans

  2007cites this paper
• [Myocardial ischemia of the driver as a cause of a traffic road accident. Immunohistochemical C9 staining method in diagnostics of early myocardial infarction].

  2006cites this paper
• Role of the Terminal Complement Components

  2005cites this paper
• Immunohistochemical detection of early myocardial infarction. An evaluation of antibodies against the terminal complement complex (C5b-9)

  2005cites this paper
• C‐reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion

  2004cites this paper
• Prevention of Cardiac Cell Injury During Acute Myocardial Infarction

  2003cites this paper
• Fatal trauma to the neck: immunohistochemical study of local injuries.

  2003cites this paper
• C‐reactive protein and rapidly progressive coronary artery disease is there any relation?

  2003cites this paper
• High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction

  2003cites this paper
• Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein

  2003cites this paper
• S‐protein is expressed in necrotic fibers in Duchenne muscular dystrophy and polymyositis

  2003cites this paper
• C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms.

  2002cites this paper
• C1-esterase inhibitor in ischemia and reperfusion.

  2002cites this paper
• Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction.

  2002cites this paper
• Assessment of in vivo complement activation on the Echinococcus granulosus hydatid cyst wall

  2001cites this paper
• Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: Examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants

  2001cites this paper
• CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?

  2001cites this paper
• Extrahepatic synthesis of complement proteins in inflammation.

  2001cites this paper
• Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement

  2001cites this paper
• Inflammation and Alzheimer's disease.

  2000cites this paper
• INFLAMMATION AND ALZHEIMERS DISEASE

  2000cites this paper
• The Regulation of C1 Activation and Its Role in Disease

  2000cites this paper
• Evaluation of the membrane attack complex of complement for the detection of a recent myocardial infarction in man

  2000cites this paper
• Inflammation and Alzheimer's disease.

  2000cites this paper
• C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.

  2000cites this paper
• Open peer commentary Inflammation and Alzheimer's disease

  2000cites this paper
• Complement Activation by C-Reactive Protein: An Inflammatory Mechanism in Human Disease?

  1999cites this paper
• Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction.

  1999cites this paper
• Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex.

  1999cites this paper
• C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

  1999cites this paper
• Preconditioning reduces tissue complement gene expression in the rabbit isolated heart.

  1999cites this paper
• Preconditioning reduces tissue complement gene expression in the rabbit isolated heart.

  1999cites this paper
• Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues.

  1999cites this paper
• Analogues Induction by Complement : Inhibition With Anti-Human C 5 Therapy or cGMP B Translocation and Vascular Cell Adhesion Molecule-1 κ Endothelial Nuclear Factor

  1999cites this paper
• Human heart generates complement proteins that are upregulated and activated after myocardial infarction.

  1998cites this paper
• Myocardial Infarction Human Heart Generates Complement Proteins That Are Upregulated and Activated After

  1998cites this paper
• X‐linked vacuolated myopathy: Membrane attack complex deposition on the surface membrane of injured muscle fibers is not accompanied by S‐protein

  1998cites this paper
• Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion.

  1998cites this paper
• High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology.

  1998cites this paper
• Components and Reactivity

  1998cites this paper
• Complement activation and regulator expression after anoxic injury of human endothelial cells

  1998cites this paper
• Pharmacological intervention to decrease ischemia-reperfusion injury

  1998cites this paper
• Endothelial Cell Biology

  1997cites this paper
• Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction

  1997cites this paper
• Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway.

  1997cites this paper
• Reperfusion injury.

  1997cites this paper
• C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction.

  1997cites this paper
• Reperfusion Injury of Ischemic Skeletal Muscle Is Mediated by Natural Antibody and Complement Materials and Methods

  1996cites this paper
• Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

  1996cites this paper
• Complement and Mechanisms of Restenosis

  1996cites this paper
• Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion

  1996cites this paper
• Reduction of Myocardial Necrosis After Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours Before Regional Ischemia and Reperfusion.

  1996cites this paper
• High-dose intravenous magnesium attenuates complement consumption after acute myocardial infarction treated by streptokinase.

  1996cites this paper
• Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections.

  1996cites this paper
• Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

  1996cites this paper
• Membrane regulators of complement activation and their aberrant expression in disease.

  1995cites this paper
• In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.

  1995cites this paper
• Cardiac manifestations in polymyositis/dermatomyositis: how to get to heart of the matter.

  1995cites this paper
• Activation of the terminal complement cascade in renal infarction.

  1995cites this paper
• Immunohistochemical detection of C5b-9(m) in myocardium: an aid in distinguishing infarction-induced ischemic heart muscle necrosis from other forms of lethal myocardial injury.

  1995cites this paper
• Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion.

  1994cites this paper
• THE COMPLEMENT SYSTEM IN TRAUMA‐RELATED AND ISCHEMIC TISSUE DAMAGE: A BRIEF REVIEW

  1994cites this paper
• Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury.

  1994cites this paper
• Complement activation and inhibition in myocardial ischemia and reperfusion injury.

  1994cites this paper
• Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung.

  1993cites this paper
• Regulation of complement membrane attack complex formation in myocardial infarction.

  1993cites this paper
• Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.

  1993cites this paper
• Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.

  1993cites this paper
• Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart.

  1993cites this paper
• Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.

  1992cites this paper
• Effects of complement activation in the isolated heart. Role of the terminal complement components.

  1992cites this paper
• Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin.

  1992cites this paper
• Blockade of Complement Activation Prevents Local and Pulmonary Albumin Leak After Lower Torso Ischemia—Reperfusion

  1992cites this paper